Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.

MLA

Zitman-Gal, Tali, et al. “Effect of Liraglutide on the Janus Kinase/Signal Transducer and Transcription Activator (JAK/STAT) Pathway in Diabetic Kidney Disease in Db/Db Mice and in Cultured Endothelial Cells.” Journal of Diabetes, vol. 11, no. 8, Aug. 2019, pp. 656–64. EBSCOhost, https://doi.org/10.1111/1753-0407.12891.

APA

Zitman-Gal, T., Einbinder, Y., Ohana, M., Katzav, A., Kartawy, A., & Benchetrit, S. (2019). Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells. Journal of Diabetes, 11(8), 656–664. https://doi.org/10.1111/1753-0407.12891

Chicago

Zitman-Gal, Tali, Yael Einbinder, Meital Ohana, Aviva Katzav, Amany Kartawy, and Sydney Benchetrit. 2019. “Effect of Liraglutide on the Janus Kinase/Signal Transducer and Transcription Activator (JAK/STAT) Pathway in Diabetic Kidney Disease in Db/Db Mice and in Cultured Endothelial Cells.” Journal of Diabetes 11 (8): 656–64. doi:10.1111/1753-0407.12891.